» Articles » PMID: 22719767

Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin During HIV-1 Infection

Overview
Journal Int J Microbiol
Publisher Wiley
Specialty Microbiology
Date 2012 Jun 22
PMID 22719767
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective. We hypothesized that HMGB1 in complex with bacterial components, such as flagellin, CpG-ODN, and LPS, promotes HIV-1 replication. Furthermore, we studied the levels of antiflagellin antibodies during HIV-1-infection. Methods. Chronically HIV-1-infected U1 cells were stimulated with necrotic extract/recombinant HMGB1 in complex with TLR ligands or alone. HIV-1 replication was estimated by p24 antigen in culture supernatants 48-72 hours after stimulation. The presence of systemic anti-flagellin IgG was determined in 51 HIV-1-infected patients and 19 controls by immunoblotting or in-house ELISA. Results. Flagellin, LPS, and CpG-ODN induced stronger HIV-1 replication when incubated together with necrotic extract or recombinant HMGB1 than activation by any of the compounds alone. Moreover, the stimulatory effect of necrotic extract was inhibited by depletion of HMGB1. Elevated levels of anti-flagellin antibodies were present in plasma from HIV-1-infected patients and significantly decreased during 2 years of antiretroviral therapy. Conclusions. Our findings implicate a possible role of HGMB1-bacterial complexes, as a consequence of microbial translocation and cell necrosis, for immune activation in HIV-1 pathogenesis. We propose that flagellin is an important microbial product, that modulates viral replication and induces adaptive immune responses in vivo.

Citing Articles

Flagellin Restricts HIV-1 Infection of Macrophages through Modulation of Viral Entry Receptors and CC Chemokines.

Zhou L, Wang X, Xiao Q, Khan S, Ho W Viruses. 2024; 16(7).

PMID: 39066226 PMC: 11281555. DOI: 10.3390/v16071063.


Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV.

Ouyang J, Yan J, Zhou X, Isnard S, Harypursat V, Cui H Front Immunol. 2023; 14:1173956.

PMID: 37153621 PMC: 10160480. DOI: 10.3389/fimmu.2023.1173956.


HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.

Khanal S, Schank M, El Gazzar M, Moorman J, Yao Z Cells. 2021; 10(2).

PMID: 33672138 PMC: 7926981. DOI: 10.3390/cells10020475.


Serum vitamin D receptor and High Mobility Group Box-1 (HMGB1) levels in HIV-infected patients with different immunodeficiency status: A cross-sectional study.

Wardani I, Hatta M, Mubin R, Bukhari A, Mulyanto , Massi M Ann Med Surg (Lond). 2021; 63:102174.

PMID: 33664952 PMC: 7900012. DOI: 10.1016/j.amsu.2021.02.020.


Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial.

Vermandere K, Bostick R, Tran H, Gewirtz A, Barry E, Rutherford R Cancer Prev Res (Phila). 2020; 14(3):393-402.

PMID: 33229339 PMC: 8137511. DOI: 10.1158/1940-6207.CAPR-20-0461.


References
1.
Hellerstein M, Hanley M, Cesar D, Siler S, Papageorgopoulos C, Wieder E . Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med. 1999; 5(1):83-9. DOI: 10.1038/4772. View

2.
Kamat A, Ancuta P, Blumberg R, Gabuzda D . Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS One. 2010; 5(11):e15533. PMC: 2981579. DOI: 10.1371/journal.pone.0015533. View

3.
Macnab R . How bacteria assemble flagella. Annu Rev Microbiol. 2003; 57:77-100. DOI: 10.1146/annurev.micro.57.030502.090832. View

4.
Jiang W, Lederman M, Hunt P, Sieg S, Haley K, Rodriguez B . Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009; 199(8):1177-85. PMC: 2728622. DOI: 10.1086/597476. View

5.
Giorgi J, Hultin L, McKeating J, Johnson T, Owens B, Jacobson L . Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999; 179(4):859-70. DOI: 10.1086/314660. View